NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹143.37
0.26%
NAV as on 05 Feb 26, 12:00 AM
very high risk
sectoral pharma
equity
NAV as on 05 Feb 26, 12:00 AM
very high risk
sectoral pharma
equity
0.97%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
12.23%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the DSP Nifty Healthcare ETF - Growth scheme from DSP Investment Managers Private Limited. It is a Sectoral-Pharma mutual fund scheme that predominantly invests in Sectoral-Pharma stocks of companies. Launched on Feb 2024, DSP Nifty Healthcare ETF - Growth is Sectoral-Pharma fund of its category with 10.83 Cr fund under management as on Feb 2026. The expense ratio of this fund is less than that of most other Fund category Sectoral-Pharma funds.
The Scheme seeks to provide returns that, before expenses, correspond to the total return of the underlying index (Nifty Healthcare TRI), subject to tracking errors.
Abbott India Ltd
1.55%
Apollo Hospitals Enterprise Ltd
7.37%
Aurobindo Pharma Ltd
3.37%
Reverse Repo
0.20%
Net Receivables
0.07%
Biocon Ltd
2.41%
Zydus Lifesciences Ltd
2.33%
Cipla Ltd
8.65%
Divi's Laboratories Ltd
8.26%
Dr. Reddy's Laboratories Ltd
7.88%
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return

low to moderate risk | liquid
0.0%

low to moderate risk | liquid
0.0%

very high risk | equity
20.3%